This story first appeared at ProPublica. ProPublica is a Pulitzer Prize-winning investigative newsroom. Sign up for The Big Story newsletter to receive stories like this one in your inbox. Meggan ...
Hosted on MSN
Incyte stock falls despite FDA breakthrough therapy fast track for rare blood cancer drug
IncyteINCY said Sunday that the Food and Drug Administration has granted Breakthrough Therapy designation to its experimental treatment for a rare blood cancer. The biotech also released updated Phase ...
NEW YORK, Jan. 05, 2026 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results